Guggenheim Capital LLC Durect Corp Transaction History

Guggenheim Capital LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2018 Aug 14, 2018	SELL	$1.56 - $2.51 $65,780 - $105,839	-42,167 Closed	0 $0
Q1 2018 May 15, 2018	SELL	$0.91 - $2.24 $895 - $2,204	-984 Reduced 2.28%	42,167 $90,000
Q4 2017 Feb 14, 2018	SELL	$0.78 - $2.1 $4,202 - $11,314	-5,388 Reduced 11.1%	43,151 $39,000
Q3 2017 Nov 14, 2017	BUY	$1.55 - $1.82 $75,235 - $88,340	48,539	48,539 $85,000

593K

Ticker DRRX
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 227,794,000
Market Cap $216M
Description
DURECT Corporation, a biopharmaceutical company, researches and develops medicines based on its epigenetic regulator and pharmaceutical programs. The company offers ALZET product line that consists of osmotic pumps and accessories used for research in mice, rats, and other laboratory animals. It also develops larsucosterol (DUR-928), an endogeno...

Get notified when there are updates to the investment portfolio of Guggenheim Capital LLC, based on Form 13F filings with the SEC.

Stay updated on Guggenheim Capital LLC with notifications on news.